WOEST Trial Summary WOEST trial was an open-label randomized controlled trial in patients who were on oral anticoagulants and underwent PCI with coronary stenting. Patients who were on oral anticoagulants and underwent PCI with coronary artery stenting (N=573) were randomly assigned to 2 groups: Dual therapy (Clopidogrel and OAC) or triple therapy (Aspirin, clopidogrel, and..
2014, 12 or 30 months of dual antiplatelet therapy after drug-eluting stents PCI, NEJM
2001, Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation, NEJM
2006, Clopidogrel and aspirin versus aspirin alone for prevention of atherothrombosis, NEJM